Day: August 31, 2022

Azerion publishes Interim Unaudited Q2 and H1 2022 Results

Written by Customer Service on August 31, 2022. Posted in Earnings Releases And Operating Results.

Resilient business model reflected in revenue and gross margin expansion The summary provided below relates to the Q2 and H1 2022 results of Azerion Holding B.V., which is the main operational holding subsidiary of Azerion Group N.V. Highlights of Q2 2022Net Revenue of EUR 104 million, nearly doubling Q2 2021, driven by acquisitions and organic growth. Adjusted EBITDA approaching EUR 12 million, up by 70% compared to Q2 2021, primarily boosted by improved net revenue and gross profit margin. Accelerated the integration of acquisitions, pointing to further synergies and productivity upside; increased focus on operational efficiencies and costs to strengthen our resilience. Partnership with ITV studios, with Love Island opening a virtual villa in Hotel Hideaway. Partnerships with Cyberkongs, Metaverse HQ and Metakey to increase the utility...

Auriant Mining AB (publ.) publishes Q2 2022 Interim Report (January – June)

Written by Customer Service on August 31, 2022. Posted in Public Companies.

Highlights Amounts in parentheses refer to the same period in the previous year.Gold production 423.1 kg / 13,605 oz (454.9 kg /14,626 oz). Gold sales 435.5 kg /14,000 oz (391.8 kg /12,598 oz) Consolidated revenue US$ 26.3 mln (US$ 22.9 mln) Net profit after tax US$ 9.7 mln (US$ 3.7 mln) EBITDA US$ 13.5 mln (US$ 10.6 mln) Net cash flow generated from operating activities US$ 7.4 mln (US$ 10.7 mln) Average selling price for gold US$ 1,878 per oz (US$ 1,821 per oz) 2022 updated annual production forecast is 800 kg of gold.Significant events after the reporting period Birgit Köster Hoffmann, member of the Board of directors of Auriant Mining AB (publ.) (the “Company”) resigned from the Company’s Board of directors for personal reasons on 18 August 2022. Birgit Köster Hoffmann joined the Company’s Board of directors in May 2021 and was...

Maxima Group’s Supervisory Board changes its composition

Written by Customer Service on August 31, 2022. Posted in Public Companies.

Laimonas Devyžis resigned from the Supervisory Board of Maxima Grupė as of 30 August this year. He is replaced on the Supervisory Board by Nerijus Maknevičius, current CEO of Galio Group. The Supervisory Board of Maxima Grupė is now composed of Mr. N. Maknevičius, Mr. Manfredas Dargužis, Chairman of the Management Board and CEO of Akropolis Group, and Ms. Evelina Černienė, CFO of Vilniaus Prekyba, who chairs the Supervisory Board. The term of office of the Supervisory Board ends in 2026. Additional information Maxima Grupė operates Maxima (Baltic States), Stokrotka (Poland), T-Market (Bulgaria) retail stores and Barbora, an online food store in the Baltic States and Poland. At the end of 2021, the Maxima Group had over 1,400 stores in five countries and revenues of €4.5 billion. The company belongs to the Vilniaus Prekyba group of companies....

Junshi Biosciences Announces 2022 Interim Financial Results and Provides Corporate Updates

Written by Customer Service on August 31, 2022. Posted in Earnings Releases And Operating Results.

— Clinical trials of core drug candidates are progressing steadily with the debut of the company’s FIH asset — Toripalimab’s sales performance is consistently improving; the US BLA is under review SHANGHAI, China, Aug. 31, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, today announced its 2022 interim financial results and provided corporate updates. FINANCIAL HIGHLIGHTSTotal revenue reached approximately RMB 946 million in the first half of 2022. In particular, the sales revenue of TUOYI® (toripalimab) was approximately RMB 298 million, representing an increase of approximately 195% compared to the second half of 2021....

Ackermans & van Haaren realises a record profit of 278.4 million euros over the first half of 2022

Written by Customer Service on August 31, 2022. Posted in Earnings Releases And Operating Results.

Dear shareholder, Dear Madam, Dear Sir,Ackermans & van Haaren realises a record profit of 278.4 million euros over the first half of 2022 thanks to:generally good results in the group’s core segments, which is reflected in a 5% higher profit contribution; a positive evolution of the Growth Capital participations, both within the consolidated participations as well as in the more recent initiatives in India and South-East Asia; the 97.2 million euros capital gain on the sale of Manuchar.After the sale of Anima (closed in July 2022 and therefore not yet included in the result as at June 30), Ackermans & van Haaren has a net cash position of more than 500 million euros.“In a challenging environment with steep cost increases, deteriorating consumer confidence and decreasing stock markets, the companies of the group...

PCI Biotech interim first-half year 2022 results

Written by Customer Service on August 31, 2022. Posted in Earnings Releases And Operating Results.

Oslo (Norway), 31 August 2022 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces its interim first-half year 2022 results. Please find enclosed the report and presentation. Highlights Corporate*The previously reported efforts to finance a Ph II clinical trial in head and neck cancer did not, under the current market conditions, result in a feasible way forward and PCI Biotech will not conduct a company-sponsored Ph II trial with the fimaVacc technology *The company will focus its efforts and resources on non-clinical research, developing further the current pipeline opportunities while exploring new fields of use for the PCI technology utilising fimaVacc for intratumoural immunotherapy, and fimaNAc for dermatology and bioprocessing applications fimaVacc – intratumoural immunotherapy*The results from...

IBA Reports Half Year 2022 Results

Written by Customer Service on August 31, 2022. Posted in Earnings Releases And Operating Results.

RECORD ORDER INTAKE AND BACKLOG ACROSS THE GROUP HIGHLY ACTIVE PIPELINE FOR ALL BUSINESS LINES SOLID BALANCE SHEET WITH RECORD EUR 137 MILLION NET CASH Louvain-la-Neuve, Belgium, 31 August 2022 – IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announces its consolidated results for the first half of 2022.(EUR 000) H1 2022 H1 2021 Variance Variance % Total Net Sales 160 032 137 183 22 849 16.7% Proton Therapy 103 026 70 473 32 553 46.2% Other Accelerators 30 110 40 285 -10 175 -25.3% Dosimetry 26 896 26 425 471 1.8% REBITDA 14 065 5 745 8 320 144.8% % of Sales 8.8% 4.2% REBIT 4 564 674 3 890 577.2% % of Sales 2.9% 0.5% Profit Before Tax 297 -843 1 140 135.2% % of Sales 0.2% -0.6% NET RESULT -1 717 -1 935 218 11.3% % of Sales -1.1% -1.4% Financial...

Kinarus Therapeutics Reports H1 2022 Financial Results and Provides Corporate Update

Written by Customer Service on August 31, 2022. Posted in Earnings Releases And Operating Results.

Interim data from Phase 2 KINETIC clinical trial of KIN001 to treat hospitalized COVID-19 patients expected in Q3 2022 First patient dosed with in Phase 2 KINFAST clinical trial with ambulatory COVID-19 mild-patients Signed a CHF 20 million financing with Yorkville Advisors Fully financed until Q1 2023Basel, Switzerland, August 31, 2022 – Kinarus Therapeutics Holding AG (SIX: KNRS), a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral, respiratory and ophthalmic diseases, today reported results for the six months ended June 30, 2022, and provided a corporate update. Dr. Alexander Bausch, CEO of Kinarus Therapeutics Holding AG, commented: “We believe we are well positioned to execute on multiple value-creating milestones. As a first of many, our experienced team is working to deliver in Q3 2022 interim...

Avance Gas Holding Ltd: Key information relating to the dividend for the second quarter 2022

Written by Customer Service on August 31, 2022. Posted in Public Companies.

Key information relating to the dividend to be paid by Avance Gas Holding Ltd. for the second quarter 2022: Dividend amount: $0.20 Declared currency: USD Last day including right: 6 September 2022 Ex-date: 7 September, 2022 Record date: 8 September, 2022 Payment date: 15 September, 2022 Date of approval: 30 August, 2022 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Avance Gas Holding Ltd: Financial Results for Q2 2022

Written by Customer Service on August 31, 2022. Posted in Earnings Releases And Operating Results.

BERMUDA, August 31 2022 – Avance Gas Holding Ltd (OSE: AGAS) (“Avance Gas” or the “Company”) today reports unaudited results for the second quarter 2022. HIGHLIGHTSThe average time charter equivalent (TCE) rate on load to discharge basis was $36,212/day compared to $37,608/day for the first quarter 2022. This was ahead of guidance of between $32,000/day to $33,000/day. Daily operating expenses (OPEX) were $8,200/day, down from $8,500/day for the first quarter. Net profit of $18.4 million compared to $24.3 million for the first quarter 2022, or earnings per share of 24 cents compared to 32 cents for the first quarter. During the second quarter 2022, the Company completed the sale of the 2008-built VLGC Providence with the vessel being delivered to the new owners in May. The sale generated a gain on sale of $4.5 million and a cash release...

Day: August 31, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice